Studies have shown that active fund managers routinely underperform the S&P500 index*​

Sionna Therapeutics, Inc. (NASDAQ: SION)

SION Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
49%

SION Stock Analysis

SION PE Ratio:

SION PEG Ratio: Not Available

SION Forward EPS Growth (12 month): 0.00%

SION PS Ratio:

SION PSG Ratio: Not Available

SION Forward Revenue Growth (12 month): 0.00%

SION Articles

No data was found